306 related articles for article (PubMed ID: 21868696)
1. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
[TBL] [Abstract][Full Text] [Related]
2. Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment.
Haberland A; Wallukat G; Schimke I
Trends Cardiovasc Med; 2011 Aug; 21(6):177-82. PubMed ID: 22814426
[TBL] [Abstract][Full Text] [Related]
3. Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies.
Wallukat G; Müller J; Haberland A; Berg S; Schulz A; Freyse EJ; Vetter R; Salzsieder E; Kreutz R; Schimke I
Atherosclerosis; 2016 Jan; 244():44-7. PubMed ID: 26584137
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes.
Christ T; Wettwer E; Dobrev D; Adolph E; Knaut M; Wallukat G; Ravens U
J Mol Cell Cardiol; 2001 Aug; 33(8):1515-25. PubMed ID: 11448139
[TBL] [Abstract][Full Text] [Related]
5. Role of β₁-adrenoceptor autoantibodies in the pathogenesis of dilated cardiomyopathy.
Dandel M; Wallukat G; Potapov E; Hetzer R
Immunobiology; 2012 May; 217(5):511-20. PubMed ID: 21820755
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against cardiac β(1)-adrenoceptor do not affect the low-affinity state β(1)-adrenoceptor-mediated inotropy in rat cardiomyocytes.
Abdelkrim MA; Mallem MY; Chatagnon G; Gogny M; Desfontis JC; Noireaud J
Can J Physiol Pharmacol; 2012 Apr; 90(4):407-14. PubMed ID: 22448877
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats.
Haberland A; Wallukat G; Berg S; Schulz AM; Freyse EJ; Vetter R; Salzsieder E; Müller J; Kreutz R; Schimke I
Mol Cell Biochem; 2014 Aug; 393(1-2):177-80. PubMed ID: 24744110
[TBL] [Abstract][Full Text] [Related]
8. Interaction between autoantibodies against the beta1-adrenoceptor and isoprenaline in enhancing L-type Ca2+ current in rat ventricular myocytes.
Christ T; Schindelhauer S; Wettwer E; Wallukat G; Ravens U
J Mol Cell Cardiol; 2006 Oct; 41(4):716-23. PubMed ID: 16889792
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients.
Wallukat G; Muñoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Duchen D; Diaz Ramirez I; Borges AC; Schimke I
J Am Coll Cardiol; 2010 Feb; 55(5):463-8. PubMed ID: 20117461
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease.
Levin MJ; Hoebeke J
Autoimmunity; 2008 Sep; 41(6):429-33. PubMed ID: 18781468
[TBL] [Abstract][Full Text] [Related]
11. Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy.
Landsberger M; Staudt A; Choudhury S; Trimpert C; Herda LR; Klingel K; Kandolf R; Schultheiss HP; Kroemer HK; Völker U; Felix SB
Am Heart J; 2008 Jul; 156(1):92-99.e2. PubMed ID: 18585502
[TBL] [Abstract][Full Text] [Related]
12. The first aptamer-apheresis column specifically for clearing blood of β1-receptor autoantibodies.
Wallukat G; Haberland A; Berg S; Schulz A; Freyse EJ; Dahmen C; Kage A; Dandel M; Vetter R; Salzsieder E; Kreutz R; Schimke I
Circ J; 2012; 76(10):2449-55. PubMed ID: 22850243
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.
Magnusson Y; Wallukat G; Waagstein F; Hjalmarson A; Hoebeke J
Circulation; 1994 Jun; 89(6):2760-7. PubMed ID: 8205690
[TBL] [Abstract][Full Text] [Related]
14. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis.
Jane-wit D; Altuntas CZ; Johnson JM; Yong S; Wickley PJ; Clark P; Wang Q; Popović ZB; Penn MS; Damron DS; Perez DM; Tuohy VK
Circulation; 2007 Jul; 116(4):399-410. PubMed ID: 17620508
[TBL] [Abstract][Full Text] [Related]
15. Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA.
Holthoff HP; Zeibig S; Jahns-Boivin V; Bauer J; Lohse MJ; Kääb S; Clauss S; Jahns R; Schlipp A; Münch G; Ungerer M
Circ Res; 2012 Aug; 111(6):675-84. PubMed ID: 22811559
[TBL] [Abstract][Full Text] [Related]
16. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease.
Elies R; Ferrari I; Wallukat G; Lebesgue D; Chiale P; Elizari M; Rosenbaum M; Hoebeke J; Levin MJ
J Immunol; 1996 Nov; 157(9):4203-11. PubMed ID: 8892658
[TBL] [Abstract][Full Text] [Related]
17. The predictive values of beta1-adrenergic and M2 muscarinic receptor autoantibodies for sudden cardiac death in patients with chronic heart failure.
Pei J; Li N; Chen J; Li X; Zhang Y; Wang Z; Zhang P; Cao K; Pu J
Eur J Heart Fail; 2012 Aug; 14(8):887-94. PubMed ID: 22713286
[TBL] [Abstract][Full Text] [Related]
18. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
[TBL] [Abstract][Full Text] [Related]
19. Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy.
Störk S; Boivin V; Horf R; Hein L; Lohse MJ; Angermann CE; Jahns R
Am Heart J; 2006 Oct; 152(4):697-704. PubMed ID: 16996841
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities.
Chiale PA; Rosenbaum MB; Elizari MV; Hjalmarson A; Magnusson Y; Wallukat G; Hoebeke J
J Am Coll Cardiol; 1995 Oct; 26(4):864-9. PubMed ID: 7560610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
